{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:11:56Z","timestamp":1791897116850,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:00:00Z","timestamp":1648512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:00:00Z","timestamp":1648512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1208\/s12249-022-02255-3","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T06:14:05Z","timestamp":1648534445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Development, Characterization, and Investigation of In Vivo Targeted Delivery Efficacy of Luteolin-Loaded, Eudragit S100-Coated mPEG-PLGA Nanoparticles"],"prefix":"10.1208","volume":"23","author":[{"given":"Xia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,29]]},"reference":[{"issue":"5","key":"2255_CR1","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","volume":"71","author":"J Zhou","year":"2020","unstructured":"Zhou J, Zhou F, Wang W, Zhang XJ, Ji YX, Zhang P, et al. Epidemiological Features of NAFLD From 1999 to 2018 in China. Hepatology. 2020;71(5):1851\u201364.","journal-title":"Hepatology"},{"issue":"8","key":"2255_CR2","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016;65(8):1038\u201348.","journal-title":"Metabolism"},{"issue":"7","key":"2255_CR3","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","volume":"13","author":"C Leung","year":"2016","unstructured":"Leung C, Rivera L, Furness JB, Angus PW. The role of the gut microbiota in NAFLD. Nat Rev Gastroenterol Hepatol. 2016;13(7):412\u201325.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1\u20132","key":"2255_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/pr.2014.157","volume":"77","author":"L Zhu","year":"2015","unstructured":"Zhu L, Baker RD, Baker SS. Gut microbiome and nonalcoholic fatty liver diseases. Pediatr Res. 2015;77(1\u20132):245\u201351.","journal-title":"Pediatr Res"},{"key":"2255_CR5","doi-asserted-by":"publisher","first-page":"108612","DOI":"10.1016\/j.biopha.2019.108612","volume":"112","author":"M Imran","year":"2019","unstructured":"Imran M, Rauf A, Abu-Izneid T, Nadeem M, Shariati MA, Khan IA, et al. Luteolin, a flavonoid, as an anticancer agent: A review [published correction appears in Biomed Pharmacother 2019 Aug; 116: 109084]. Biomed Pharmacother. 2019;112:108612.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"2255_CR6","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1021\/acs.jnatprod.6b00146","volume":"79","author":"V Francisco","year":"2016","unstructured":"Francisco V, Figueirinha A, Costa G, Liberal J, Ferreira I, Lopes MC, et al. The Flavone Luteolin Inhibits Liver X Receptor Activation. J Nat Prod. 2016;79(5):1423\u20138.","journal-title":"J Nat Prod"},{"issue":"1","key":"2255_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3945\/ajcn.116.136051","volume":"105","author":"A Cassidy","year":"2017","unstructured":"Cassidy A, Minihane AM. The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids. Am J Clin Nutr. 2017;105(1):10\u201322.","journal-title":"Am J Clin Nutr"},{"issue":"139","key":"2255_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.bcp.2017.04.033","volume":"1","author":"JC Esp\u00edn","year":"2017","unstructured":"Esp\u00edn JC, Gonz\u00e1lez-Sarr\u00edas A, Tom\u00e1s-Barber\u00e1n FA. The gut microbiota: A key factor in the therapeutic effects of (poly)phenols. Biochem Pharmacol. 2017 1(139):82\u201393.","journal-title":"Biochem Pharmacol"},{"key":"2255_CR9","doi-asserted-by":"publisher","first-page":"109019","DOI":"10.1016\/j.abb.2021.109019","volume":"711","author":"X Liu","year":"2021","unstructured":"Liu X, Sun R, Li Z, Xiao R, Lv P, Sun X, et al. Luteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis. Arch Biochem Biophys. 2021;711:109019.","journal-title":"Arch Biochem Biophys"},{"issue":"32","key":"2255_CR10","doi-asserted-by":"publisher","first-page":"e1900262","DOI":"10.1002\/smll.201900262","volume":"15","author":"J Liu","year":"2019","unstructured":"Liu J, Zhang R, Xu ZP. Nanoparticle-Based Nanomedicines to Promote Cancer Immunotherapy: Recent Advances and Future Directions. Small. 2019;15(32):e1900262.","journal-title":"Small"},{"issue":"1\u20132","key":"2255_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijpharm.2015.06.007","volume":"491","author":"SK Vemula","year":"2015","unstructured":"Vemula SK. Formulation and pharmacokinetics of colon-specific double-compression coated mini-tablets: Chronopharmaceutical delivery of ketorolac tromethamine. Int J Pharm. 2015;491(1\u20132):35\u201341.","journal-title":"Int J Pharm"},{"issue":"2","key":"2255_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jconrel.2005.02.011","volume":"104","author":"A Lamprecht","year":"2005","unstructured":"Lamprecht A, Yamamoto H, Takeuchi H, Kawashima Y. A pH-sensitive microsphere system for the colon delivery of tacrolimus containing nanoparticles. J Control Release. 2005;104(2):337\u201346.","journal-title":"J Control Release"},{"issue":"1","key":"2255_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0168-3659(98)00029-7","volume":"55","author":"M Rodr\u00edguez","year":"1998","unstructured":"Rodr\u00edguez M, Vila-Jato JL, Torres D. Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region. J Control Release. 1998;55(1):67\u201377.","journal-title":"J Control Release"},{"issue":"1","key":"2255_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ijpharm.2017.08.076","volume":"531","author":"A Saneja","year":"2017","unstructured":"Saneja A, Kumar R, Singh A, Dhar Dubey R, Mintoo MJ, Singh G, et al. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy. Int J Pharm. 2017;531(1):153\u201366.","journal-title":"Int J Pharm"},{"key":"2255_CR15","doi-asserted-by":"crossref","unstructured":"Beloqui A, Coco R, Memvanga PB, Ucakar B, des Rieux A, Pr\u00e9at V. pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease. Int J Pharm 2014: 473(1\u20132):203\u2013212","DOI":"10.1016\/j.ijpharm.2014.07.009"},{"key":"2255_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jconrel.2014.03.039","volume":"183","author":"H Ali","year":"2014","unstructured":"Ali H, Weigmann B, Neurath MF, Collnot EM, Windbergs M, Lehr CM. Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases. J Control Release. 2014;183:167\u201377.","journal-title":"J Control Release"},{"issue":"9","key":"2255_CR17","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1211\/0022357011776658","volume":"53","author":"M Rodriguez","year":"2001","unstructured":"Rodriguez M, Ant\u00fanez JA, Taboada C, Seijo B, Torres D. Colon-specific delivery of budesonide from microencapsulated cellulosic cores: evaluation of the efficacy against colonic inflammation in rats. J Pharm Pharmacol. 2001;53(9):1207\u201315.","journal-title":"J Pharm Pharmacol"},{"key":"2255_CR18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3389\/fchem.2020.00407","volume":"8","author":"R Zhao","year":"2020","unstructured":"Zhao R, Zhu M, Zhou S, Feng W, Chen H. Rapamycin-Loaded mPEG-PLGA Nanoparticles Ameliorate Hepatic Steatosis and Liver Injury in Non-alcoholic Fatty Liver Disease. Front Chem. 2020;8:407.","journal-title":"Front Chem"},{"key":"2255_CR19","doi-asserted-by":"publisher","first-page":"794299","DOI":"10.3389\/fmed.2021.794299","volume":"8","author":"S Wu","year":"2021","unstructured":"Wu S, Mao Y, Liu Q, Yan X, Zhang J, Wang N. Sustained Release of Gas6 via mPEG-PLGA Nanoparticles Enhances the Therapeutic Effects of MERTK Gene Therapy in RCS Rats. Front Med (Lausanne). 2021;8:794299.","journal-title":"Front Med (Lausanne)."},{"issue":"9","key":"2255_CR20","doi-asserted-by":"publisher","first-page":"9217","DOI":"10.1021\/acsnano.5b03876","volume":"9","author":"Q Xu","year":"2015","unstructured":"Xu Q, Ensign LM, Boylan NJ, Sch\u00f6n A, Gong X, Yang JC, et al. Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in Vivo. ACS Nano. 2015;9(9):9217\u201327.","journal-title":"ACS Nano"},{"issue":"4","key":"2255_CR21","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/mp800051m","volume":"5","author":"F Alexis","year":"2008","unstructured":"Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm. 2008;5(4):505\u201315.","journal-title":"Mol Pharm"},{"issue":"1","key":"2255_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.001","volume":"75","author":"A Kumari","year":"2010","unstructured":"Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 2010;75(1):1\u201318.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"2","key":"2255_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10856-015-5641-x","volume":"27","author":"Q Guan","year":"2016","unstructured":"Guan Q, Sun S, Li X, Lv S, Xu T, Sun J, et al. Preparation, in vitro and in vivo evaluation of mPEG-PLGA nanoparticles co-loaded with syringopicroside and hydroxytyrosol. J Mater Sci Mater Med. 2016;27(2):24.","journal-title":"J Mater Sci Mater Med"},{"key":"2255_CR24","doi-asserted-by":"publisher","first-page":"120138","DOI":"10.1016\/j.ijpharm.2020.120138","volume":"593","author":"N Lammari","year":"2021","unstructured":"Lammari N, Demautis T, Louaer O, Meniai AH, Casabianca H, Bensouici C, et al. Nanocapsules containing Saussurea lappa essential oil: Formulation, characterization, antidiabetic, anti-cholinesterase and anti-inflammatory potentials. Int J Pharm. 2021;593:120138.","journal-title":"Int J Pharm."},{"key":"2255_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijbiomac.2017.10.103","volume":"110","author":"AI Oliveira","year":"2018","unstructured":"Oliveira AI, Pinho C, Fonte P, Sarmento B, Dias ACP. Development, characterization, antioxidant and hepatoprotective properties of poly(\u0190-caprolactone) nanoparticles loaded with a neuroprotective fraction of Hypericum perforatum. Int J Biol Macromol. 2018;110:185\u201396.","journal-title":"Int J Biol Macromol"},{"issue":"11","key":"2255_CR26","doi-asserted-by":"publisher","first-page":"181457","DOI":"10.1098\/rsos.181457.","volume":"5","author":"S Wan","year":"2018","unstructured":"Wan S, Zhang L, Quan Y, Wei K. Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy. R Soc Open Sci. 2018 5(11):181457. https:\/\/doi.org\/10.1098\/rsos.181457. (Erratum. In: R Soc Open Sci.\u00a02019;6(1):182173).","journal-title":"R Soc Open Sci"},{"issue":"2","key":"2255_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0026-2862(83)90016-X","volume":"25","author":"M Turner","year":"1983","unstructured":"Turner M, Clough G, Michel C. The effects of cationised ferritin and native ferritin upon the filtration coefficient of single frog capillaries. Evidence that proteins in the endothelial cell coat influence permeability. Microvasc Res. 1983;25(2):205\u201322.","journal-title":"Microvasc Res."},{"issue":"3","key":"2255_CR28","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1161\/01.RES.79.3.581","volume":"79","author":"H Vink","year":"1996","unstructured":"Vink H, Duling BR. Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ Res. 1996;79(3):581\u20139.","journal-title":"Circ Res"},{"issue":"9","key":"2255_CR29","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1054\/bjoc.1999.1171","volume":"82","author":"M Dellian","year":"2000","unstructured":"Dellian M, Yuan F, Trubetskoy V, Torchilin V, Jain R. Vascular permeability in a human tumour xenograft: molecular charge dependence. Br J Cancer. 2000;82(9):1513\u20138.","journal-title":"Br J Cancer"},{"issue":"1","key":"2255_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15171\/apb.2020.001","volume":"10","author":"SK Joseph","year":"2020","unstructured":"Joseph SK, Sabitha M, Nair SC. Stimuli-Responsive Polymeric Nanosystem for Colon Specific Drug Delivery. Adv Pharm Bull. 2020;10(1):1\u201312.","journal-title":"Adv Pharm Bull"},{"key":"2255_CR31","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.2147\/IJN.S46613","volume":"8","author":"SW Tsai","year":"2013","unstructured":"Tsai SW, Yu DS, Tsao SW, Hsu FY. Hyaluronan-cisplatin conjugate nanoparticles embedded in Eudragit S100-coated pectin\/alginate microbeads for colon drug delivery. Int J Nanomedicine. 2013;8:2399\u2013407.","journal-title":"Int J Nanomedicine"},{"key":"2255_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08982104.2021.1999974","volume":"13","author":"G Wang","year":"2021","unstructured":"Wang G, Yang Y, Yi D, Yuan L, Yin PH, Ke X, et al. Eudragit S100 prepared pH-responsive liposomes-loaded betulinic acid against colorectal cancer in vitro and in vivo. J Liposome Res. 2021 13:1\u201315.","journal-title":"J Liposome Res"},{"issue":"1\u20132","key":"2255_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0378-5173(01)00574-9","volume":"220","author":"AH El-Kamel","year":"2001","unstructured":"El-Kamel AH, Sokar MS, Al Gamal SS, Naggar VF. Preparation and evaluation of ketoprofen floating oral delivery system. Int J Pharm. 2001;220(1\u20132):13\u201321.","journal-title":"Int J Pharm"},{"issue":"8","key":"2255_CR34","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/bmc.1370","volume":"24","author":"X Chen","year":"2010","unstructured":"Chen X, Liu L, Sun Z, Liu Y, Xu J, Liu S, et al. Pharmacokinetics of luteolin and tetra-acetyl-luteolin assayed by HPLC in rats after oral administration. Biomed Chromatogr. 2010;24(8):826\u201332.","journal-title":"Biomed Chromatogr"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-022-02255-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-022-02255-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-022-02255-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T05:08:32Z","timestamp":1726895312000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-022-02255-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,29]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["2255"],"URL":"https:\/\/doi.org\/10.1208\/s12249-022-02255-3","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,29]]},"assertion":[{"value":"25 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"100"}}